ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2022 Results

LOS ANGELES–(BUSINESS WIRE)—- $CDXC #earnings–ChromaDex Corp. (NASDAQ:CDXC) today announced fourth quarter and fiscal year 2022 financial results. Fourth Quarter 2022 and Recent Highlights Total net sales were $21.0 million, up 18% from $17.8 million for the prior year quarter. Tru Niagen® net sales were $16.1 million, up 14% from $14.1…